期刊文献+

不同药性清热中药体外抗产ESBLs大肠埃希菌效果及分析 被引量:11

不同药性清热中药体外抗产ESBLs大肠埃希菌效果及分析
下载PDF
导出
摘要 目的筛选对耐西药产超广谱β-内酰胺酶(ESBLs)敏感的单味中药,为中药治疗耐西药菌提供思路和方法。方法选用8味具有清热作用的中药制成水煎剂原药,用琼脂二倍稀释法进行体外抑菌效果观察。结果黄芩、黄连、黄柏、知母、连翘、大青叶、金银花、板蓝根8种中药单味水煎剂对产ESBLs大肠埃希菌20株临床株均有不同程度的抑菌作用,其中以黄芩、黄连及连翘抗菌效果较好。结论体外实验证明,中药中存在对耐西药产ESBLs大肠埃希菌有较好抗菌作用的单味中药。 Objective To screen resistant western medicine production of extended- spectrum β -lactamases (ESBLs) single- sensitive Chinese medicine and provide ideas and methods for Chinese medicine treatment of resistant bacteria infections. Methods 8 removal of heat taste with the role of traditional Chinese medicina .decoction made from the original drug twice by agar dilution method.The bacter-iostatic effect in vitro were observed. Results Scutellaria baicalensis Georgi, Coptis chinensis Franch, Phellodendron amurense Rupr., Anemarrhena asphodloides Bge., Forsythia, suspense Vahl, Isatis indigotica Fort., Lonicerajaponica Thunb., Root of Isatis indigotica Fort, 8 single kinds of traditional Chinese medicine had varying degrees bacteriostasis on ESBLs producing 20 clinical strains of Escherichia coli in.Among them, Scutellaria baicalensis Georgi, Coptis chinensis Franch and Forsythia had better antibacterial effect. Conclusion Vitro experiments show that the existence of single kind of traditional Chinese medicine have good antibacterial effects of single herbs in Western medicineresistant E. coli producing ESBLs.
出处 《当代医学》 2009年第25期149-150,共2页 Contemporary Medicine
基金 咸阳市星火计划基金资助项目(项目编号:K05014-3)
关键词 不同药性 清热中药 产超广谱Β-内酰胺酶大肠埃希菌 抗菌效果 Different properties of Chinese medicine Chinese medicine of removal of heat E.coli producing ESBLs Antibacterial effect
  • 相关文献

参考文献3

二级参考文献42

  • 1欧阳范献,卜平凤,陈允凤,黄瑾.铜绿假单胞菌ESBLs检测及其流行病学分析[J].中国热带医学,2004,4(4):519-521. 被引量:6
  • 2季淑娟,顾怡明,谭文涛,王丹丹,冯羡菊,周志慧,俞云松,陈亚岗,李兰娟.中国部分地区大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶基因型研究[J].中华检验医学杂志,2004,27(9):590-593. 被引量:172
  • 3程玉林,陈民钧.吉戈菲肠杆菌中SHV-2耐药基因的序列分析[J].微生物学报,1994,34(3):226-230. 被引量:3
  • 4陈民钧,俞云松,王辉,徐英春.改进药敏折点标准 指导临床合理选择抗菌药物[J].中华检验医学杂志,2005,28(6):565-568. 被引量:17
  • 5Goossens H.MYSTIC program:summary of European data from 1997 to 2000.Diagn Microbiol Infect Dis,2001,41:183-189.
  • 6Yu YS,Zhou WL,Chen YG,et al.Epidemiological and antibiotic resistant study on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.Chin Med J,2002,115:1479-1482.
  • 7Paterson DL,Mulazimoglu L,Casellas JM,et al.Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.Clin Infect Dis,2000,30:473-478.
  • 8Yu WL,Jones RN,Hollis RJ,et al.Molecular epidemiology of extended-spectrum β-lactamase producing,fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan.J Clin Microbiol,2002,40:4666-4669.
  • 9Bedenic B,Beader N,Zagar Z.Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended spectrum beta-lactamases.Clin Microbiol Infect,2001,7:626-635.
  • 10Medeiros AA.Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics.Clin Infect Dis,1997,24:S19-S45.

共引文献112

同被引文献199

引证文献11

二级引证文献245

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部